Sign in

CIK 0000873303

  • Large accelerated filer

Sarepta Therapeutics, Inc.

Sign in to watch
Ticker
SRPT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
930797222
Phone
+1 617-274-4000
Business address
215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
Former names
Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-03-01 Arif Bilal Chief Tech Ops Officer Grant or award +6,000 28,836
2024-03-01 Arif Bilal Chief Tech Ops Officer Sale −1,543 $128.58 $198K 27,293
2024-03-01 Arif Bilal Chief Tech Ops Officer Sale −457 $129.71 $59K 26,836
2024-03-01 Arif Bilal Chief Tech Ops Officer Shares withheld for taxes −114 $126.19 $14K 26,722
2024-03-01 Arif Bilal Chief Tech Ops Officer Grant or award · Stock Option (right to buy) −12,500 12,500
2024-03-01 Estepan Ian Michael Chief Financial Officer Shares withheld for taxes −365 $126.19 $46K 34,314
2024-03-01 Estepan Ian Michael Chief Financial Officer Grant or award +6,000 40,314
2024-03-01 Estepan Ian Michael Chief Financial Officer Sale −1,200 $128.30 $154K 39,114
2024-03-01 Estepan Ian Michael Chief Financial Officer Grant or award · Stock Option (right to buy) −12,500 12,500
2023-12-01 Arif Bilal Chief Tech Ops Officer Shares withheld for taxes −3,682 $80.34 $296K 22,886
2023-11-17 Rodino-Klapac Louise Head of R&D, CSO Shares withheld for taxes −4,508 $82.98 $374K 65,751
2023-11-03 Barry Richard Director Purchase +10,000 $78.81 $788K 10,000
2023-11-03 Barry Richard Director Purchase +40,000 $78.81 $3.2M 140,000
2023-11-03 INGRAM DOUGLAS S President & CEO Purchase +10,081 $78.57 $792K 375,163
2023-11-03 INGRAM DOUGLAS S President & CEO Purchase +11,060 $79.70 $881K 386,223
2023-11-03 INGRAM DOUGLAS S President & CEO Purchase +3,884 $80.33 $312K 390,107
2023-11-03 INGRAM DOUGLAS S President & CEO Purchase +200 $81.26 $16K 390,307
2023-11-03 BEHRENS M KATHLEEN Director Exercise or conversion +15,000 $29.03 $435K 174,993
2023-11-03 BEHRENS M KATHLEEN Director Exercise or conversion · Stock Option (Right to Buy) −15,000 0
2023-08-14 Chambers Michael Andrew Director Purchase +5,947 $109.19 $649K 242,964

Page 14 of 22 · 424 trades